Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Titel:
Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Auteur:
Babiker, H.M. Brana, I. Mahadevan, D. Owonikoko, T.K. Calvo, E. Rischin, D. Moreno, V. Papadopoulos, K.P. Crittenden, M. Formenti, S. Giralt, J. Garrido, P. Hervás Morón, A. Mohan, K.K. Fury, M.G. Lowy, I. Stankevich, E. Feng, M. Li, J. Mathias, M.